These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 16482517)

  • 41. Ephrin-B3 ligand promotes glioma invasion through activation of Rac1.
    Nakada M; Drake KL; Nakada S; Niska JA; Berens ME
    Cancer Res; 2006 Sep; 66(17):8492-500. PubMed ID: 16951161
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expression of the oncogene c-erbB-2 in canine mammary cancers and tumor-derived cell lines.
    Ahern TE; Bird RC; Bird AE; Wolfe LG
    Am J Vet Res; 1996 May; 57(5):693-6. PubMed ID: 8723884
    [TBL] [Abstract][Full Text] [Related]  

  • 43. HMG-I(Y) recognizes base-unpairing regions of matrix attachment sequences and its increased expression is directly linked to metastatic breast cancer phenotype.
    Liu WM; Guerra-Vladusic FK; Kurakata S; Lupu R; Kohwi-Shigematsu T
    Cancer Res; 1999 Nov; 59(22):5695-703. PubMed ID: 10582687
    [TBL] [Abstract][Full Text] [Related]  

  • 44. gamma-heregulin is the product of a chromosomal translocation fusing the DOC4 and HGL/NRG1 genes in the MDA-MB-175 breast cancer cell line.
    Wang XZ; Jolicoeur EM; Conte N; Chaffanet M; Zhang Y; Mozziconacci MJ; Feiner H; Birnbaum D; Pébusque MJ; Ron D
    Oncogene; 1999 Oct; 18(41):5718-21. PubMed ID: 10523851
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Heregulin stimulates mitogenesis and phosphatidylinositol 3-kinase in mouse fibroblasts transfected with erbB2/neu and erbB3.
    Carraway KL; Soltoff SP; Diamonti AJ; Cantley LC
    J Biol Chem; 1995 Mar; 270(13):7111-6. PubMed ID: 7535767
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Changes in heregulin beta1 (HRGbeta1) signaling after inhibition of ErbB-2 expression in a human breast cancer cell line.
    Yoo JY; Hamburger AW
    Mol Cell Endocrinol; 1998 Mar; 138(1-2):163-71. PubMed ID: 9685225
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Study of inhibition effect of herceptin on interaction between heregulin and erbB receptors HER3/HER2 by single-molecule force spectroscopy.
    Shi X; Xu L; Yu J; Fang X
    Exp Cell Res; 2009 Oct; 315(16):2847-55. PubMed ID: 19497323
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Activation of mitogen-activated protein kinase in estrogen receptor alpha-positive breast cancer cells in vitro induces an in vivo molecular phenotype of estrogen receptor alpha-negative human breast tumors.
    Creighton CJ; Hilger AM; Murthy S; Rae JM; Chinnaiyan AM; El-Ashry D
    Cancer Res; 2006 Apr; 66(7):3903-11. PubMed ID: 16585219
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Activation of the alpha2beta1 integrin prevents c-erbB2-induced scattering and apoptosis of human mammary epithelial cells in collagen.
    Baeckström D; Lu PJ; Taylor-Papadimitriou J
    Oncogene; 2000 Sep; 19(40):4592-603. PubMed ID: 11030148
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Growth factor regulation of a 26S proteasomal subunit in breast cancer.
    Barnes CJ; Li F; Talukder AH; Kumar R
    Clin Cancer Res; 2005 Apr; 11(8):2868-74. PubMed ID: 15837734
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Involvement of heregulin-beta2 in the acquisition of the hormone-independent phenotype of breast cancer cells.
    Tang CK; Perez C; Grunt T; Waibel C; Cho C; Lupu R
    Cancer Res; 1996 Jul; 56(14):3350-8. PubMed ID: 8764133
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Epidermal growth factor receptor-dependent activation of Gab1 is involved in ErbB-2-mediated mammary tumor progression.
    Gillgrass A; Cardiff RD; Sharan N; Kannan S; Muller WJ
    Oncogene; 2003 Dec; 22(57):9151-5. PubMed ID: 14668796
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rassf3 is responsible in part for resistance to mammary tumor development in neu transgenic mice.
    Jacquemart IC; Springs AE; Chen WY
    Int J Oncol; 2009 Feb; 34(2):517-28. PubMed ID: 19148488
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Heregulin and retinoids synergistically induce branching morphogenesis of breast cancer cells cultivated in 3D collagen gels.
    Offterdinger M; Schneider SM; Grunt TW
    J Cell Physiol; 2003 May; 195(2):260-75. PubMed ID: 12652653
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Signaling molecules implicated in heregulin induction of growth arrest and apoptosis.
    Guerra-Vladusic FK; Vladusic EA; Tsai MS; Lupu R
    Oncol Rep; 2001; 8(6):1203-14. PubMed ID: 11605034
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Overexpression of RasN17 fails to neutralize endogenous Ras in MCF7 breast cancer cells.
    Yuste L; Esparís-Ogando A; Santos E; Pandiella A
    J Biochem; 2005 Jun; 137(6):731-9. PubMed ID: 16002995
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Endogenous expression of Neuregulin-1 (Nrg1) as a potential modulator of prolactin (PRL) secretion in GH3 cells.
    Zhao W; Shen Y; Ren S
    Cell Tissue Res; 2011 May; 344(2):313-20. PubMed ID: 21437657
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Extracellular matrix enhances heregulin-dependent BRCA1 phosphorylation and suppresses BRCA1 expression through its C terminus.
    Miralem T; Avraham HK
    Mol Cell Biol; 2003 Jan; 23(2):579-93. PubMed ID: 12509456
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The serine protease inhibitor protease nexin-1 controls mammary cancer metastasis through LRP-1-mediated MMP-9 expression.
    Fayard B; Bianchi F; Dey J; Moreno E; Djaffer S; Hynes NE; Monard D
    Cancer Res; 2009 Jul; 69(14):5690-8. PubMed ID: 19584287
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Constitutive expression of Heregulin induces apoptosis in an erbB-2 overexpressing breast cancer cell line SKBr-3.
    Guerra-Vladusic FK; Scott G; Weaver V; Vladusic EA; Tsai MS; Benz CC; Lupu R
    Int J Oncol; 1999 Nov; 15(5):883-92. PubMed ID: 10536169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.